Triple Hair | Corporate and science news

Publications

Corporate, science and informational news

Keep up to date with the latest developments at Triple Hair! Check out our various publications to stay abreast of our scientific advances and the company’s growth.

All ALOPECIA Corporate In the medias Science

October 23, 2024

Corporate

Triple Hair Group Enters Into Licensing Agreement with Akums for Therapy-07 in India

June 19, 2024

Corporate

Triple Hair Group Receives EMA Approval to Start Phase III Clinical Trials on its Therapy-07 Prescription Drug in Europe

June 11, 2024

In the medias

Triple Hair Group Signs Licensing Agreement for South Korean Market with Mother’s Pharmaceutical

July 27, 2023

Corporate

OpportunitiesNB Article on an interview with our CEO Jean-Phillipe Gravel

June 28, 2023

Corporate

Triple Hair Group receives Health Canada approval to start Phase III clinical trials on its Therapy-07 prescription drug in Canada

June 22, 2023

ALOPECIA

Can anxiety or even mental health affect hair loss?

June 19, 2023

Corporate

Triple Hair Group Enters Into Licensing Agreement with Akums for Therapy-07 in India

Triple Hair Group Receives EMA Approval to Start Phase III Clinical Trials on its Therapy-07 Prescription Drug in Europe

Triple Hair’s Feature in Le Journal de Montréal

Triple Hair Group Closes $4 Million Financing

Triple Hair Wins “Jury’s Choice Award” at Octane Aesthetic Tech Forum

Triple Hair Group Signs Licensing Agreement for South Korean Market with Mother’s Pharmaceutical

OpportunitiesNB Article on an interview with our CEO Jean-Phillipe Gravel

Triple Hair Group receives Health Canada approval to start Phase III clinical trials on its Therapy-07 prescription drug in Canada

Can anxiety or even mental health affect hair loss?

Triple Hair Group consolidates its position as industry leader and innovator for its Therapy-07 prescription drug in the U.S.